(PharmaNewsWire.Com, June 20, 2019 ) According to the new market research report “Cell Signaling Market by Type (Endocrine, Paracrine), Pathway (Akt, AMPK, Hedgehog, Notch), Product (Consumables, Instruments), Technology (Flow Cytometry, ELISA, Mass Spectrometry) & Application (Research, Cancer, Immunology) — Global Forecast”, published by MarketsandMarkets™, report provides a detailed overview of the major drivers, restraints, challenges, opportunities, and strategies impacting the global Cell Signaling Market along with the estimates and forecasts of the revenue and market share analysis.
Growth in the Cell Signaling Market is driven by the rising incidence of chronic diseases, availability of funding for cell-based research, technological advancements in cell-based research instruments, and the growth of the life science and biopharmaceutical industries.
This report segments the Cell Signaling Market on the basis of product, pathway, signaling type, technology, application, and region.
Based on the product, the market is segmented into consumables and instruments. The cell signaling consumables segment is estimated to account for the largest share of the Cell Signaling Market in 2017. The increasing number of cell signaling research activities and the rising incidence of chronic diseases are some of the major factors contributing to the segments large market share.
Browse and in-depth TOC on “Cell Signaling Market”
157 — Tables
76 — Figures
212 — Pages
Based on the signaling type, the market is segmented into paracrine, endocrine, autocrine, juxtacrine, and other signaling types (intracrine and neuronal signaling). The endocrine segment is estimated to account for the largest share of the Cell Signaling Market.
Based on application, the market is segmented into research applications (cancer research, immunology research, stem cells research, and other research applications) and medical applications. The research applications segment is estimated to account for the largest share of the Cell Signaling Market.
On the basis of region, the market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). North America is estimated to account for the largest share of the Cell Signaling. Growth in this regional segment is driven by the growth in geriatric population, rising incidence of chronic diseases, and improved life science research infrastructure in the region.
The key players in the Cell Signaling Market include Merck KGaA (Germany), Thermo Fisher Scientific Inc. (U.S.), Becton, Dickinson and Company (U.S.), Beckman Coulter, Inc. (U.S.) (a subsidiary of Danaher Corporation), Bio-Rad Laboratories, Inc. (U.S.), PerkinElmer Inc. (U.S.), QIAGEN N.V. (Netherlands), Cell Signaling Technology, Inc. (U.S.), Promega Corporation (U.S.), Bio-Techne Corporation (U.S.), Abcam plc (U.K.), Miltenyi Biotec (Germany)
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
